The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Cellular function of the mononuclear phagocyte system (MPS) as a phenotypic probe for pharmacokinetics (PK) and pharmacodynamics (PD) of PEGylated liposomal doxorubicin (PLD) in patients with recurrent ovarian cancer.
Whitney Paige Caron
No relevant relationships to disclose
John C. Lay
No relevant relationships to disclose
Parag Kumar
No relevant relationships to disclose
Alan M. Fong
No relevant relationships to disclose
Ninh My La-Beck
No relevant relationships to disclose
Suzanne E. Newman
No relevant relationships to disclose
Daniel L. Clarke-Pearson
No relevant relationships to disclose
Wendy R. Brewster
No relevant relationships to disclose
Linda Van Le
No relevant relationships to disclose
Victoria Lin Bae-Jump
No relevant relationships to disclose
Paola A. Gehrig
No relevant relationships to disclose
William Zamboni
No relevant relationships to disclose